Clinical Trials Directory

Trials / Completed

CompletedNCT01722370

Ambulatory Oxygen Effects on Muscles in COPD

Can Muscle Dysfunction in COPD be Altered by Oxygenation in Patients With Intermittent Hypoxia on Exertion?

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
25 (actual)
Sponsor
University of Birmingham · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients with chronic obstructive pulmonary disease (COPD) may develop low oxygen levels, because of damage to their lungs. Long term oxygen therapy (LTOT) is given for at least 15 hours per day, and has established indications and benefits in COPD. However, the indications for and benefits from ambulatory oxygen supplementation (oxygen just when walking or exercising) are less well understood, in part due to heterogeneity of previous study designs, and lack of long term follow up. This is a pilot study of supplementary ambulatory oxygen in COPD, which allows us to ascertain mechanisms of disease by measuring their degree of systemic inflammation pre and post oxygen supplementation, and measuring changes in gene expression in muscles by means of microarray profiling. Secondly, our study will utilise follow up of clinical parameters including home activity monitoring to ascertain medium/long term benefits of oxygen supplementation in a real life setting. Our hypothesis is that exertional hypoxia results in muscle dysfunction and this could be prevented by oxygenation.

Conditions

Interventions

TypeNameDescription
DRUGOxygen
DRUGMedical air equivalent

Timeline

Start date
2012-08-01
Primary completion
2014-11-01
Completion
2014-11-01
First posted
2012-11-06
Last updated
2014-12-03

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01722370. Inclusion in this directory is not an endorsement.